4
Changes in Ownership
BridgeBio Pharma, Inc. Filed Acc 0000899243-20-032503
Chief Business Officer sold 784 shares at $30.04 ($23,549)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| HENDERSON MICHAEL THOMAS Chief Business Officer | 2020-06-03 | Sale | −784 | $30.04 | $23,549 | 261,399 | D: show line 1 in the form |
| Open-market sales · 784 sh · avg $30.04 · $23,549 | |||||||
Loading xslF345X03/doc4.xml…